Analysis of Primary-Refractory Hodgkin Lymphoma Pts in a Randomized, Placebo-Controlled Study of Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplant.

Analysis of Primary-Refractory Hodgkin Lymphoma Pts in a Randomized, Placebo-Controlled Study of Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplant. Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):14-5 Authors: PMID: 26862874 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research